HCW Biologics (HCWB) Research & Development (2021 - 2025)
Historic Research & Development for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to $1.4 million.
- HCW Biologics' Research & Development rose 1831.09% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 3098.52%. This contributed to the annual value of $6.4 million for FY2024, which is 1677.0% down from last year.
- Latest data reveals that HCW Biologics reported Research & Development of $1.4 million as of Q3 2025, which was up 1831.09% from $1.2 million recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Research & Development ranged from a high of $2.9 million in Q4 2022 and a low of $1.0 million during Q4 2024
- In the last 5 years, HCW Biologics' Research & Development had a median value of $1.8 million in 2022 and averaged $1.9 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 9753.24% in 2022, then plummeted by 5087.0% in 2024.
- Over the past 5 years, HCW Biologics' Research & Development (Quarter) stood at $1.5 million in 2021, then skyrocketed by 97.53% to $2.9 million in 2022, then dropped by 27.09% to $2.1 million in 2023, then crashed by 50.87% to $1.0 million in 2024, then soared by 33.79% to $1.4 million in 2025.
- Its last three reported values are $1.4 million in Q3 2025, $1.2 million for Q2 2025, and $1.5 million during Q1 2025.